表紙
市場調査レポート

世界の卵巣癌市場

Global Ovarian Cancer Market 2014-2018

発行 TechNavio (Infiniti Research Ltd.) 商品コード 306331
出版日 ページ情報 英文 45 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
世界の卵巣癌市場 Global Ovarian Cancer Market 2014-2018
出版日: 2014年06月13日 ページ情報: 英文 45 Pages
概要

卵巣癌は卵巣組織に悪性腫瘍が形成されるもので、世界の主な婦人科系癌のひとつとなっています。卵巣癌は初期段階では診断が難しく、症状は膨満感や腹部の不快感といった胃腸疾患のそれと似ています。診断技術が十分に確立されていないため、進行癌の段階で診断されたときにはすでに転移していることが多いのです。しかし卵巣癌は化学療法や標的療法、手術などで治療が可能です。現在卵巣癌治療のための薬剤数は限られていますが、豊富な数の薬剤が開発中です。世界の卵巣癌市場は2013〜2018年にCAGR13.85%っで拡大すると予測されています。

当レポートでは、世界の卵巣癌市場の現状と将来的見通しについて調査し、今後の市場規模、主な市場動向と成長牽引因子、市場の機会と脅威、主要ベンダーのプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 当レポートの範囲

  • 市場概要
  • 製品概要
    • 製品プロファイル

第4章 市場調査方法

第5章 イントロダクション

第6章 市場環境

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第7章 発症率と罹患率

第8章 治療別市場セグメンテーション

  • 化学療法
  • 標的療法

第9章 パイプラインポートフォリオ

第10章 地域別セグメンテーション

第11章 購買基準

第12章 市場成長牽引因子

第13章 牽引因子とその影響

第14章 市場の課題

第15章 牽引因子と課題の影響

第16章 市場動向

第17章 動向とその影響

第18章 ベンダー環境

  • 競合シナリオ
    • 最新情報
    • 合併・買収
  • 市場シェア分析
  • その他の注目すべきベンダー

第19章 主要ベンダー分析

第20章 当シリーズのレポート紹介

図表

目次
Product Code: IRTNTR3651

About Ovarian Cancer and its therapy

Ovarian cancer is a condition where a malignancy forms in the ovarian tissue and is caused by uncontrollable cell growth. It is one of the major gynaecological cancers worldwide and a leading cause of death. Ovarian cancer is difficult to diagnose in the initial stages because the symptoms are similar to that of gastric disorders like bloating, abdominal discomfort, difficulty in eating in the early stage and nausea, vomiting, constipation and diarrhoea in the later stages. It is often diagnosed in advanced stages when the metastasis has set in because the diagnostic techniques are not well-developed. Ovarian cancer can be treated by using chemotherapy, targeted therapy, and surgery. Although the market has a limited number of drugs for the treatment of ovarian cancer currently, a strong product pipeline is in development for the forecast period.

TechNavio's analysts forecast the Global Ovarian Cancer market will grow at a CAGR of 13.85 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Ovarian Cancer market for the period 2013-2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of ovarian cancer that are available in the market.

TechNavio's report, the Global Ovarian Cancer Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Ovarian Cancer market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Bristol Myers Squibb Company
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Janssen Pharmaceuticals Inc.
  • F. Hoffman-La Roche Ltd

Other Prominent Vendors

  • Aprea AB
  • Aetera Zenteris Inc.
  • Amgen Inc.
  • Astra Zeneca plc
  • Bionumerik Pharmaceuticals Inc.
  • Boehringer Ingelheim GmbH
  • Genentech Inc.
  • MEI Pharmaceuticals Inc.
  • Nektar Therapeutics
  • NeoPharm Inc.
  • Novogen Inc.
  • Oasmia Pharmaceuticals AB
  • Synta Pharmaceuticals Corp.

Key Market Driver

  • Promising Drug Pipeline.

For a full, detailed list, view our report.

Key Market Challenge

  • Lack of Accurate Diagnosis of Ovarian Cancer.

For a full, detailed list, view our report.

Key Market Trend

  • Increase in the Funding Activities.

For a full, detailed list, view our report.

Key questions answered in this report:

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings
    • Product Profiles

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Rate of Incidence and Prevalence

08. Market Segmentation by Type of Therapy

  • 08.1.1. Chemotherapy
  • 08.1.2. Targeted Therapy

09. Pipeline Portfolio

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

  • 18.1. Competitive Scenario
    • 18.1.1. Key News
    • 18.1.2. Mergers and Acquisitions
  • 18.2. Market Share Analysis 2013
  • 18.3. Other Prominent Vendors

19. Key Vendor Analysis

20. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Ovarian Cancer Market 2013-2018 (US$ billion)
  • Exhibit 3: Global Ovarian Cancer Market 2013-2018 by Type of Therapy
  • Exhibit 4: Snapshot of Ovarian Cancer Pipeline 2013
  • Exhibit 5: Global Ovarian Cancer Market by Geographical Segmentation 2013
Back to Top